Meril v Edwards Lifesciences (CoA, 18 April 2025)
| Date | 18 April 2025 |
|---|---|
| Court | CoA |
| Division | Luxembourg (LU) |
| Type of action | Application Rop 223 |
| Registry reference | App_9095/2025 · ORD_10080/2025 |
| Parties | Meril Gmbh, Meril Life Sciences Pvt Ltd. v. Edwards Lifesciences Corporation |
Official decision (PDF) · UPC registry entry
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
By order of 18 April 2025 (UPC_CoA_166/2025), the Court of Appeal rejects the application by Meril GmbH and Meril Life Sciences for suspensive effect of their appeal against the Munich Local Division’s decision of 15 November 2024, as rectified on 17 February 2025, finding infringement of Edwards Lifesciences’ EP 3 646 825, or alternatively for a stay of enforcement against security. The order confirms that enforceability pending appeal is the rule and that arguments going to the merits of the appeal do not establish a manifest error.
Question
Should an appeal against an infringement decision have suspensive effect, or enforcement be stayed against security, where the appellant alleges errors of claim construction, a breach of the right to be heard and a pending appeal on validity?
Decision
An appeal has no suspensive effect save in exceptional circumstances, such as a manifestly erroneous decision or an appeal that would otherwise become devoid of purpose (paragraph 13). The appeal is not devoid of purpose, since Edwards undertook not to publish the decision (paragraph 14), claim construction and the other grounds are for the appeal on the merits (paragraph 15). A pending appeal on revocation is not enough on its own (paragraph 22). The alternative request, based on Rules 223.1 and 352.1, lacks a proper legal basis and runs against the rule that decisions are enforceable pending appeal (paragraphs 27 and 28). Costs are not decided (paragraph 30).
Key points for practice
- A stay of enforcement against security cannot rest on Rules 223.1 and 352.1, which concern suspensive effect and the binding effect of decisions (paragraph 27).
- Complying with the decision and then waiting more than three months before applying undermines any claim of urgency (paragraph 18).
Provisions applied
- Agreement on a Unified Patent Court
- Art. 74(1)
- Rules of Procedure
- Rules 118.2(a), 118.8, 223.1 and 352.1
- Case law cited
- Court of Appeal, 19 June 2024, ICPillar v ARM (UPC_CoA_301/2024), Court of Appeal, 29 October 2024, Belkin v Philips (UPC_CoA_549/2024).
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Going further
Lexicon: UPC Court of Appeal.
Dhenne Avocats blog: UPC Appeals: What the Numbers Show.
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Proceedings
Parties
- defendantEdwards Lifesciences Corporation41 decisions in the corpusFollow this party
- claimantMeril Gmbh45 decisions in the corpusFollow this party
- claimantMeril Life Sciences Pvt Ltd.32 decisions in the corpusFollow this party
Decisions in the same proceedings and documented appeals
What the record states
- Nature of the act
- Application Rop 223
- Outcome (Dhenne Avocats summary)
- La cour d’appel refuse l’effet suspensif à l’appel de Meril contre la décision de contrefaçon de la division locale de Munich et rejette la demande subsidiaire de suspension de l’exécution contre garantie, faute de base juridique.
- Appeal
- Decision of the Court of Appeal.
- Instance
- Court of Appeal decision.
Patents mentioned
EP 3 646 825mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- Koninklijke Philips v Belkin (CoA, 29 October 2024) cited in this record
- ICPillar v ARM (CoA, 19 June 2024) cited in this record
Patents and standards
| Publication | Role in the dispute | Family | Standard and declaration | Pool | Sources |
|---|---|---|---|---|---|
EP 3 646 825A system comprising a prosthetic valve and a delivery catheter recorded proprietor: Edwards Lifesciences Corp | Mentioned in the analysis (role not qualified) Also mentioned in 32 other decision(s): Edwards Lifesciences v Meril Life Sciences (CFI, 15 November 2024) · Meril Italy v Edwards Lifesciences (CFI, 19 July 2024) · Meril v Edwards Lifesciences (CFI, 19 July 2024) · Meril Italy v Edwards Lifesciences (CoA, 25 November 2025) · Edwards Lifesciences v Sintec (CFI, 5 September 2025) · Meril Italy v SWAT Medical (CoA, 5 May 2025) · Meril v SWAT Medical (CoA, 5 May 2025) · Meril Life Sciences v SWAT Medical (CoA, 5 May 2025) | not recorded | not recorded | not recorded | Espacenet · European Patent Register existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically) mentioned in: Dhenne Avocats analysis |
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.